Literature DB >> 22579480

HBV genotypes prevalence, precore and basal core mutants in Morocco.

Warda Baha1, My Mustapha Ennaji, Fatiha Lazar, Marouane Melloul, Elmostafa El Fahime, Abdelouahad El Malki, Abdelouaheb Bennani.   

Abstract

The study of hepatitis B virus (HBV) genomic heterogeneity has become a major issue in investigations aimed at understanding the relationship between HBV mutants and the wide spectrum of clinical and pathological conditions associated with HBV infection. The objective of the current study was to find out the pattern of HBV genotypes circulating in Morocco and to investigate the precore (PC) and basal core promoter (BCP) mutants' status in Moroccan chronic hepatitis B patients. Viral genotypes were determined in 221 chronic carriers using INNO-LiPA HBV assay and hemi-nested PCR. Phylogenetic analysis was performed in 70 samples, and multiplex PCR method was used to confirm some genotyping results. PC and CP mutants were determined using Inno-Lipa. All isolates were successfully genotyped. The genotype distribution was D in 90.45% of cases, A (5.9%), E (1 case), and mixed genotypes (5 A/D and 2 D/F) in 3.17% patients. HBV carried in the HBV/D samples could be assigned to D7 (63.3%), D1 (32.7%) and 2% of strains to each D4 and D5, all HBV/A belonged to A2 subgenotype and HBV/E strain could not be sub-genotyped. In 70 studied strains, HBV mutants were detected in 88.6% of cases; PC mutants were detected in (40%) of patients and 21.5% present a mixture of wild type and G1896A mutation. BCP mutants were observed in 65.7% of cases, 22.9% were found to have the T1762/1764A double mutation, 18.6% had A1762/1764T mutation and 22.9% of patients showed the A1762T/G1764A double mutation with either A1762T/G1764T mutation. Co-infection by PC and BCP mutants was detected in 52.9% of cases. Movement from place to place most likely shapes the observed genotype distribution and consequent prevalence of genotypes other than A2 or D7 in this population. High circulation of PC and BCP mutants is common in chronic hepatitis B infection in Morocco.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22579480     DOI: 10.1016/j.meegid.2012.04.026

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  10 in total

1.  Prevalence of Hepatitis B Virus Infection Markers among Patients of the Ibn Sina University Hospital Center (Rabat, Morocco).

Authors:  Mourad Feindiri; Hakima Kabbaj; Mohammed El Mzibri; Bouchra Belkadi; Najat Bouihat; Abdelkarim Filali-Maltouf; Myriam Seffar
Journal:  Intervirology       Date:  2021-09-10       Impact factor: 2.294

2.  Disparate distribution of hepatitis B virus genotypes in four sub-Saharan African countries.

Authors:  Joseph C Forbi; Yousr Ben-Ayed; Guo-liang Xia; Gilberto Vaughan; Jan Drobeniuc; William M Switzer; Yury E Khudyakov
Journal:  J Clin Virol       Date:  2013-07-17       Impact factor: 3.168

3.  Molecular characterization of hepatitis B virus in blood donors in Botswana.

Authors:  Wonderful T Choga; Motswedi Anderson; Edward Zumbika; Sikhulile Moyo; Tshepiso Mbangiwa; Bonolo B Phinius; Pinkie Melamu; Mukendi K Kayembe; Ishmael Kasvosve; Theresa K Sebunya; Jason T Blackard; Max Essex; Rosemary M Musonda; Simani Gaseitsiwe
Journal:  Virus Genes       Date:  2018-10-31       Impact factor: 2.332

Review 4.  Hepatitis B virus genotypes: global distribution and clinical importance.

Authors:  Mustafa Sunbul
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

5.  A rare HBV subgenotype D4 with unique genomic signatures identified in north-eastern India--an emerging clinical challenge?

Authors:  Priyanka Banerjee; Rajiv Kumar Mondal; Madhuparna Nandi; Sumantra Ghosh; Mousumi Khatun; Nabendu Chakraborty; Swatilekha Bhattacharya; Arindam RoyChoudhury; Soma Banerjee; Amal Santra; Samir Sil; Abhijit Chowdhury; Pradip Bhaumik; Simanti Datta
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

6.  Nucleotide Substitutions in Hepatitis B Viruses Derived from Chronic HBV Patients.

Authors:  Narjes Shokatpour; Maryam Vaezjalali; Graham R Foster; Shahnaz Sali
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-07-01       Impact factor: 2.576

7.  Performance Comparison of the artus HBV QS-RGQ and the CAP/CTM HBV v2.0 Assays regarding Hepatitis B Virus DNA Quantification.

Authors:  Salma Madihi; Hashim Syed; Fatiha Lazar; Abdelmajid Zyad; Abdelouaheb Benani
Journal:  Biomed Res Int       Date:  2020-04-14       Impact factor: 3.411

8.  Disproportionate Distribution of HBV Genotypes A and D and the Recombinant Genotype D/E in the High and Low HBV Endemic Regions of Uganda: A Wake-Up Call for Regional Specific HBV Management.

Authors:  Hussein Mukasa Kafeero; Dorothy Ndagire; Ponsiano Ocama; Charles Drago Kato; Eddie Wampande; Henry Kajumbula; David Kateete; Abdul Walusansa; Ali Kudamba; Kigozi Edgar; Fred Ashaba Katabazi; Maria Magdalene Namaganda; Jamilu E Ssenku; Hakim Sendagire
Journal:  Int J Hepatol       Date:  2022-01-11

9.  Variability in the precore and core promoter regions of HBV strains in Morocco: characterization and impact on liver disease progression.

Authors:  Bouchra Kitab; Abdellah Essaid El Feydi; Rajaa Afifi; Christian Trepo; Mustapha Benazzouz; Wafaa Essamri; Fabien Zoulim; Isabelle Chemin; Hanane Salih Alj; Sayeh Ezzikouri; Soumaya Benjelloun
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

Review 10.  A review of the infection-associated cancers in North African countries.

Authors:  Wafaa Mohamed Hussein; Wagida A Anwar; Mohammed Attaleb; Loubna Mazini; Asta Försti; Roxana-Delia Trimbitas; Meriem Khyatti
Journal:  Infect Agent Cancer       Date:  2016-08-10       Impact factor: 2.965

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.